# @Novartis on Twitter

- **Type:** Image
- **Original URL:** https://twitter.com/Novartis/status/1041658027152162816
- **Gondola URL:** https://gondola.cc/posts/27662046-Novartis-twitter
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/9b03a60752.jpg
- **Posted:** 2018-09-17T12:00:01.000+00:00
- **Account Owner:** Novartis (@Novartis) — https://gondola.cc/Novartis

## Caption

Reliable biomarkers are needed to predict treatment responses. New ones, such as serum GAL3, are being investigated for #SevereAllergicAsthma https://t.co/7bR2AU3n7F #ERSCongress https://t.co/n7O7MCW4Zq

## Stats

- **Views:** 0
- **Likes:** 13
- **Shares:** 4
- **Comments:** 1

## Tags

severeallergicasthma, erscongress

---
Copyright (c) Gondola